[Treatment of alopecia areata totalis and maligna with Solvezink (author's transl)].
Treatment with Solvezink has been performed in 284 patients: 42 with alopecia areata, 106 with alopecia totalis (preserved axillar and pubic air as well as eyelashes and brows) and 136 with alopecia maligna. The duration of the treatment including maintenance therapy was up to 6 years. In patients with alopecia areata a state without relapse of 1 to 4 years was achieved in 42,8% of cases, in alopecia totalis and maligna a maintenance therapy was necessary to ensure a permanent regrowth of the hair. When applied correctly, Solvezink was well tolerated. The dosages and the treatment intervals of the treatment should be adjusted individually.
D000284:Administration, Oral; D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D015032:Zinc / Q000008:administration & dosage / Q000627:therapeutic use*
D015032:Zinc
Behandlung von Alopecia areata totalis und maligna mit Solvezink.